RSV Vaccines in Adults: A Risk-Based Approach
Dec 27, 2023•10 min•Ep. 368
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In this episode, Angela Branche, MD, discusses RSV vaccines in older adults, including:
- Current Advisory Committee on Immunization Practices recommendations
- Risk factors associated with severe RSV disease, including RSV-related hospitalizations
- Approach to stratifying risk factors (eg, age, comorbidities) in determining which adults may benefit from the RSV vaccine
- Ongoing research on RSV vaccines in younger adults (eg, aged 40s and 50s years) with chronic comorbidities
- Health disparities related to RSV vaccines
- Considerations for a risk-based approach, rather than age alone, to determine vaccine candidacy
Faculty:
Angela Branche, MD
Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of Rochester
Rochester, New York
Link to full program:
https://bit.ly/3nb25xe
Link to downloadable slides:
https://bit.ly/3TsXym5
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
For the best experience, listen in Metacast app for iOS or Android